يعرض 1 - 20 نتائج من 135 نتيجة بحث عن '"Ozatilgan, A."', وقت الاستعلام: 0.70s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal
  3. 3
    Academic Journal

    المساهمون: 1Department of Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands. Electronic address: r.dewit@erasmusmc.nl. 2Department of Urology, Asklepios Tumorzentrum, Hamburg, Germany. 3Department of Medical Oncology, University Hospital 12 de Octubre, Madrid, Spain. 4Department of Urology, Medical University of Vienna, Vienna, Austria. 5Department of Medical Oncology, Institute Jean Godinot, Reims, France. 6Division of Hematology and Medical Oncology, Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, USA. 7Department of Cancer Medicine, Institut Gustave Roussy, Villejuif, France, University of Paris Saclay, Saint-Aubin, France. 8Institut de Recherche Clinique, Université Catholique de Louvain, Louvain, Belgium. 9Department of Clinical Therapeutics, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece. 10Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain. 11Medical Oncology Unit, Azienda Ospedaliera Universitaria Integrata (AOUI), Verona, Italy, Department of Medical Oncology, Fondazione Policlinico Agostino Gemelli IRCCS, Rome, Italy. 12Department of Oncology, Palacky University Medical School and Teaching Hospital, Olomouc, Czech Republic. 13Department of Oncology, Landspitali University Hospital, Reykjavik, Iceland. 14Department of Oncology, Foch Hospital, Suresnes, France. 15Studienpraxis Urologie, Nürtingen, Germany. 16Hôpital d'Instruction des Armées Bégin, Saint Mandé, France. 17Global Medical Oncology, Sanofi, Cambridge, USA. 18Europe Medical Oncology, Sanofi, Paris, France. 19Division of Clinical Studies, The Institute of Cancer Research, London, UK, Prostate Targeted Therapy Group, Royal Marsden Hospital, London, UK.

    المصدر: ESMO open ; 6 ; 5 ; 100241 ; MAO12 ; England

    Relation: https://www.sciencedirect.com/science/article/pii/S2059702921002027?via%3Dihub; de Wit R, Wülfing C, Castellano D, et al. Baseline neutrophil-to-lymphocyte ratio as a predictive and prognostic biomarker in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel versus abiraterone or enzalutamide in the CARD study. ESMO Open. 2021;6(5):100241. doi:10.1016/j.esmoop.2021.100241; http://hdl.handle.net/2336/622016; ESMO open

  4. 4
    Academic Journal
  5. 5
    Academic Journal
  6. 6
    Academic Journal

    المساهمون: UCL - SSS/IREC/CHEX - Pôle de chirgurgie expérimentale et transplantation, UCL - (SLuc) Service d'urologie

    المصدر: Japanese Journal of Clinical Pathology, Vol. 51, no. 8, p. 1287-1297 (2021)

    مصطلحات موضوعية: chemo-urology, clinical trials, urology

    Relation: info:eu-repo/grantAgreement/Sanofi//; boreal:244404; http://hdl.handle.net/2078.1/244404; info:pmid/33738495; urn:ISSN:0368-2811; urn:EISSN:1465-3621

  7. 7
    Academic Journal
  8. 8
    Academic Journal
  9. 9
    Academic Journal
  10. 10
    Academic Journal

    المساهمون: Sumanasuriya, Semini, Seed, George, Parr, Harry, Rescigno, Pasquale, Goodall, Jane, Lord, Christopher, Pettitt, Stephen, Sharp, Adam, Carreira, Suzanne, De Bono, Johann

    وصف الملف: Print-Electronic; 253; application/pdf

    Relation: European urology, 2021, 80 (2), pp. 243 - 253; https://repository.icr.ac.uk/handle/internal/4801

  11. 11
    Academic Journal
  12. 12
    Academic Journal
  13. 13
    Academic Journal
  14. 14
  15. 15
  16. 16
  17. 17
    Academic Journal
  18. 18
  19. 19
  20. 20
    Academic Journal